FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

DuPont Nutrition Bd-102 Nf Recall

BD-102 NF, Microcrystalline Cellulose, NF, Ph

DuPont Nutrition USA, Inc · Newark, DE

Risk level
Class III
Reported by FDA
Mar 8, 2023
Recall ID
D-0352-2023
Check your lot numberHow we source this data

Summary

DuPont Nutrition recalled Bd-102 Nf starting Feb 1, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0352-2023 on Mar 8, 2023. Reason: Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Product description

BD-102 NF, Microcrystalline Cellulose, NF, Ph. Eur., Jp., Net Content/Gross Weight 20.0 KG / 21.1 KG bulk container, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711, USA. Headquarters: DuPont Nutrition Biosciences ApS, Langebrogade 1, Copenhagen, Denmark

Lot numbers, UPCs & expiration codes

Batch # 2173784100, B220834549 These excipients are noted not to have an expiration date.

Where it was sold

Product was distributed nationwide in the United States and Puerto Rico, and to Australia, China, Canada, Columbia, Mexico, Brazil, Malaysia, Chile, Dominic Republic, Singapore, Thailand, Ireland, Germany, South Korea, Argentina, Pakistan, Oman, India

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0352-2023
Classification
Class III
Status
Terminated
Recall initiated
Feb 1, 2023
FDA report date
Mar 8, 2023
Quantity
106,560 kg. polyethylene lined fiber drums, boxes & sacks
Recall type
Voluntary: Firm initiated
Recalling firm
DuPont Nutrition USA, Inc

Original FDA data

Every field from FDA enforcement report D-0352-2023, exactly as published.

Show all FDA fields
City
Newark
State
DE
Status
Terminated
Country
United States
Event ID
91616
Address
1301 Ogletown Rd
Code information
Batch # 2173784100, B220834549 These excipients are noted not to have an expiration date.
Postal code
19711-5419
Report date
Mar 8, 2023
Product type
Drugs
Recall number
D-0352-2023
Classification
Class III
Recalling firm
DuPont Nutrition USA, Inc
Product quantity
106,560 kg. polyethylene lined fiber drums, boxes & sacks
Termination date
Dec 20, 2023
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
BD-102 NF, Microcrystalline Cellulose, NF, Ph. Eur., Jp., Net Content/Gross Weight 20.0 KG / 21.1 KG bulk container, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711, USA. Headquarters: DuPont Nutrition Biosciences ApS, Langebrogade 1, Copenhagen, Denmark
Distribution pattern
Product was distributed nationwide in the United States and Puerto Rico, and to Australia, China, Canada, Columbia, Mexico, Brazil, Malaysia, Chile, Dominic Republic, Singapore, Thailand, Ireland, Germany, South Korea, Argentina, Pakistan, Oman, India
Recall initiation date
Feb 1, 2023
Initial firm notification
Letter
Center classification date
Feb 24, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0352-2023, published Mar 8, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls